Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.1%

1 terminated out of 14 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

14%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (6)
P 2 (2)
P 3 (1)
P 4 (1)

Trial Status

Unknown5
Completed4
Recruiting3
Terminated1
Withdrawn1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
Showing all 14 trials

Research Network

Activity Timeline